Dioxin exposure is an environmental risk factor for ischemic heart disease

Epidemiologic studies have linked dioxin exposure to increased mortality caused by ischemic heart disease. To test the hypothesis that dioxin exposure may constitute an environmental risk factor for atherosclerosis, we exposed C57BL/6J mice to 5 μg/kg of dioxin daily for 3 d, and measured various molecular and physiological markers of heart disease. Dioxin treatment led to an increase in the urinary excretion of vasoactive eicosanoids and an elevation in the mean tail-cuffblood pressure. In addition, dioxin exposure led to an increase in triglycerides, but not in high-density lipoproteins, in both Apoe(+/+) mice and in hyperlipidemic Apoe(−/−) mice. Dioxin exposure also led to an increase in low-density lipoproteins in Apoe(−/−) mice. After treatment, dioxin was associated with low-density lipoprotein particles, which might serve as a vehicle to deliver the compound to atherosclerotic plaques. Dioxin treatment of vascular smooth-muscle cells taken from C57Bl/6J mice resulted in the deregulation of several genes involved in cell proliferation and apoptosis. Subchronic treatment of Apoe(−/−) mice with dioxin (150 ng/kg, three times weekly) for 7 or 26 wk caused a trend toward earlier onset and greater severity of atherosclerotic lesions compared to those of vehicle treated mice. These results suggest that dioxin may increase the incidence of ischemic heart disease by exacerbating its severity.

[1]  J. Landers,et al.  The Ah receptor and the mechanism of dioxin toxicity. , 1991, The Biochemical journal.

[2]  J. Stegeman,et al.  Cytochrome P450IA1 induction and localization in endothelium of vertebrate (teleost) heart. , 1989, Molecular pharmacology.

[3]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[4]  R. Pollenz.  The aryl-hydrocarbon receptor, but not the aryl-hydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and nonhepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1996, Molecular pharmacology.

[5]  D. Flesch‐Janys,et al.  Exposure to polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide-producing plant in Hamburg, Federal Republic of Germany. , 1995, American journal of epidemiology.

[6]  S. Safe,et al.  Modulation of protooncogene expression in rat aortic smooth muscle cells by benzo[a]pyrene. , 1993, Archives of biochemistry and biophysics.

[7]  D. Flesch‐Janys,et al.  Cancer mortality among workers in chemical plant contaminated with dioxin , 1991, The Lancet.

[8]  D W Nebert,et al.  P450 genes: structure, evolution, and regulation. , 1987, Annual review of biochemistry.

[9]  M. Medvedovic,et al.  The transcriptional signature of dioxin in human hepatoma HepG2 cells. , 2000, Biochemical pharmacology.

[10]  R. Estabrook,et al.  Cytochrome P450 and the arachidonate cascade 1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  A. Puga,et al.  Dioxin activates HIV-1 gene expression by an oxidative stress pathway requiring a functional cytochrome P450 CYP1A1 enzyme. , 1995, Environmental health perspectives.

[12]  H. Knapp,et al.  Arachidonic Acid Diols Produced by Cytochrome P-450 Monooxygenases Are Incorporated into Phospholipids of Vascular Endothelial Cells* , 1996, The Journal of Biological Chemistry.

[13]  C. Valeri,et al.  Leukotrienes but not Complement Mediate Limb Ischemia‐Induced Lung Injury , 1989, Annals of surgery.

[14]  S. Shapiro,et al.  Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. , 1983, The New England journal of medicine.

[15]  C. Elferink,et al.  A Direct Interaction between the Aryl Hydrocarbon Receptor and Retinoblastoma Protein , 1998, The Journal of Biological Chemistry.

[16]  F. Matsumura,et al.  Regulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of the DNA binding activity of transcriptional factors via nuclear protein phosphorylation in guinea pig adipose tissue. , 1995, Biochemical pharmacology.

[17]  A. Koff,et al.  p27Kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells , 1999 .

[18]  M. DeVito,et al.  Comparisons of estimated human body burdens of dioxinlike chemicals and TCDD body burdens in experimentally exposed animals. , 1995, Environmental health perspectives.

[19]  J. Michalek,et al.  The Air Force health study: An epidemiologic investigation of health effects in Air Force personnel following exposure to herbicides, serum dioxin analysis of 1987 examination results , 1992 .

[20]  Trends in ischemic heart disease mortality--United States, 1980-1988. , 1992, MMWR. Morbidity and mortality weekly report.

[21]  N. Maeda,et al.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Bohm,et al.  Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. , 1997, Biochemical pharmacology.

[23]  D. Waxman,et al.  Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase. , 1990, The Journal of biological chemistry.

[24]  A. Koff,et al.  p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. , 1999, Genes & development.

[25]  B. Ames,et al.  Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Valeri,et al.  Mast cells and leukotrienes mediate neutrophil sequestration and lung edema after remote ischemia in rodents. , 1992, Surgery.

[27]  D. Nebert,et al.  Stable expression of mouse Cyp1a1 and human CYP1A2 cDNAs transfected into mouse hepatoma cells lacking detectable P450 enzyme activity. , 1990, DNA and cell biology.

[28]  S. Schwartz,et al.  Developmentally regulated cytochrome P-450IA1 expression in cultured rat vascular smooth muscle cells. , 1991, The Journal of biological chemistry.

[29]  B. Paigen,et al.  Effect of 3-methylcholanthrene on atherosclerosis in two congenic strains of mice with different susceptibilities to methylcholanthrene-induced tumors. , 1986, Cancer research.

[30]  M. Karmazyn,et al.  Effects of epoxyeicosatrienoic acids on isolated hearts and ventricular myocytes. , 1993, The American journal of physiology.

[31]  C. Elferink,et al.  Maximal aryl hydrocarbon receptor activity depends on an interaction with the retinoblastoma protein. , 2001, Molecular pharmacology.

[32]  K. Nephew,et al.  Activation of transcription factors activator protein-1 and nuclear factor-kappaB by 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 2000, Biochemical pharmacology.

[33]  A. Lusis,et al.  Lipoprotein oxidation and gene expression in the artery wall. New opportunities for pharmacologic intervention in atherosclerosis. , 1993, Biochemical pharmacology.

[34]  K. Ramos,et al.  Primary cultures of rat aortic endothelial and smooth muscle cells: I. An in vitro model to study xenobiotic-induced vascular cytotoxicity , 1987, In Vitro Cellular & Developmental Biology.

[35]  M. Denison,et al.  Regulation of prostaglandin endoperoxide H synthase-2 expression by 2,3,7,8,-tetrachlorodibenzo-p-dioxin. , 1996, Archives of biochemistry and biophysics.

[36]  R. Luebke,et al.  Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice. , 1995, Toxicology and applied pharmacology.

[37]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[38]  J. Reiners,et al.  Aryl Hydrocarbon Receptor Regulation of Ceramide-induced Apoptosis in Murine Hepatoma 1c1c7 Cells , 1999, The Journal of Biological Chemistry.

[39]  T. Blanck,et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin increases cardiac myocyte intracellular calcium and progressively impairs ventricular contractile responses to isoproterenol and to calcium in chick embryo hearts. , 1993, Molecular pharmacology.

[40]  L. Birnbaum.  Developmental effects of dioxins. , 1995, Environmental health perspectives.

[41]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[42]  E. Knudsen,et al.  Aromatic Hydrocarbon Receptor Interaction with the Retinoblastoma Protein Potentiates Repression of E2F-dependent Transcription and Cell Cycle Arrest* , 2000, The Journal of Biological Chemistry.

[43]  L. Birnbaum.  The mechanism of dioxin toxicity: relationship to risk assessment. , 1994, Environmental health perspectives.

[44]  J. Siewert,et al.  Inhibition of cytochromes P4501A by nitric oxide. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Umans,et al.  Nitric oxide in the regulation of blood flow and arterial pressure. , 1995, Annual review of physiology.

[46]  R. Levi,et al.  Heart as a target organ in 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity: decreased beta-adrenergic responsiveness and evidence of increased intracellular calcium. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Aviram.  Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. , 1983, Biochemical medicine.

[48]  P. A. Honchar,et al.  Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1991, The New England journal of medicine.

[49]  F. Matsumura,et al.  Rabbit serum hypertriglyceridemia after administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). , 1988, Journal of toxicology and environmental health.

[50]  K. Ramos,et al.  Growth-related signaling as a target of toxic insult in vascular smooth muscle cells: implications in atherogenesis. , 1995, Life sciences.

[51]  L. Birnbaum,et al.  Disposition and excretion of intravenous 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in rats. , 1991, Toxicology and applied pharmacology.

[52]  C. J. Omiecinski,et al.  Expression of cytochrome P450s and microsomal epoxide hydrolase in primary cultures of human umbilical vein endothelial cells. , 1994, Toxicology and applied pharmacology.

[53]  J. Vane,et al.  Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[54]  A Poland,et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. , 1982, Annual review of pharmacology and toxicology.

[55]  R. A. Neal,et al.  Characterization of the hyperlipidemia in guinea pigs induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1981, Toxicology and applied pharmacology.

[56]  D. Nebert,et al.  Dioxin causes a sustained oxidative stress response in the mouse. , 1998, Biochemical and biophysical research communications.

[57]  R. Ross,et al.  Cell biology of atherosclerosis. , 1995, Annual review of physiology.

[58]  D. Nebert,et al.  The murine Cyp1a-1 gene negatively regulates its own transcription and that of other members of the aromatic hydrocarbon-responsive [Ah] gene battery. , 1990, Molecular endocrinology.

[59]  D. Waxman,et al.  Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. , 1995, Archives of biochemistry and biophysics.

[60]  M. Gannon,et al.  Beta-naphthoflavone induction of a cytochrome P-450 arachidonic acid epoxygenase in chick embryo liver distinct from the aryl hydrocarbon hydroxylase and from phenobarbital-induced arachidonate epoxygenase. , 1992, The Journal of biological chemistry.

[61]  Matthew W. Strobeck,et al.  Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest , 2000, Oncogene.

[62]  R. Estabrook,et al.  Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. , 1981, Proceedings of the National Academy of Sciences of the United States of America.